-transparent.png){kind=logo}
The levels of serum prolactin were studied both after an acute intake of zimelidine and during a treatment period of 3--7 weeks. No significant changes in basal serum prolactin levels were seen after single oral doses of zimelidine (100 mg) in healthy volunteers during an investigation period of 12 h. Serum prolactin concentrations remained well within the pretreatment levels also during a continuous treatment of depressive patients with zimelidine up to 150 mg orally b.i.d. It is concluded that clinical doses of the selective 5-HT uptake inhibitor zimelidine does not exert any significant effect on serum prolactin levels.
Related Publications
E Syvälahti, and
A Nagy, and
H M van Praag
January 1981,
Acta psychiatrica Scandinavica. Supplementum,
E Syvälahti, and
A Nagy, and
H M van Praag
January 1979,
Acta psychiatrica Scandinavica,
E Syvälahti, and
A Nagy, and
H M van Praag
January 1981,
Acta psychiatrica Scandinavica. Supplementum,
E Syvälahti, and
A Nagy, and
H M van Praag
January 1984,
Psychopharmacology,
E Syvälahti, and
A Nagy, and
H M van Praag
March 1984,
European journal of pharmacology,
E Syvälahti, and
A Nagy, and
H M van Praag
March 1977,
Acta pharmacologica et toxicologica,
E Syvälahti, and
A Nagy, and
H M van Praag
January 1989,
Neuropharmacology,
E Syvälahti, and
A Nagy, and
H M van Praag
January 1987,
Journal of psychopharmacology (Oxford, England),
E Syvälahti, and
A Nagy, and
H M van Praag
January 1984,
Psychoneuroendocrinology,
E Syvälahti, and
A Nagy, and
H M van Praag
January 1982,
European journal of clinical pharmacology,
